A null mutation in the murine gene encoding steroid 5␣-reductase type 1 (5␣R1) leads to failure of normal parturition at term. This observation, together with the finding that mRNA levels of uterine 5␣R1 increase significantly at term in normal pregnant animals, indicates that 5␣R1 plays an important role in murine parturition. The current studies were conducted to elucidate the regulation of 5␣R1 in uterine tissues of nonpregnant and pregnant animals. Nonpregnant, ovariectomized ICR mice were treated with vehicle (control), 17␤-estradiol (E 2 ), progesterone (P 4 ), or E 2 ؉P 4 for 3 days. Thereafter, uterine tissues were obtained for histology, quantification of 5␣R1 specific activity, and Northern blot analysis of 5␣R1 mRNA expression. The 5␣R1 enzyme activity was significantly increased in animals treated with E 2 ؉P 4 . However, activity was much less in uterine tissues from E 2 ؉P 4 -treated animals than in uterine tissues from pregnant animals near term. To evaluate further the regulation of 5␣R1 during gestation, mice underwent unilateral tubal ligation before timed matings. The 5␣R1 activity increased eightfold in uterine tissues from the fetal horn from Gestational Days 12 to 18. This temporal pattern in 5␣R1 activity paralleled marked increases in uterine diameter. Taken together, these studies indicate that expression of 5␣R1 is regulated by E 2 ؉P 4 in uterine tissues. Whereas E 2 alone is insufficient to induce enzyme activity, E 2 may be required to increase P 4 receptors and, thereby, mediate the effects of P 4 on 5␣R1 gene expression. Further increases in enzyme activity during late gestation are mediated by fetal occupancy, possibly through stretch-induced increases in endometrial growth. Thus, like other genes involved in parturition, expression of 5␣R1 is regulated by both hormonal and fetal-derived signaling pathways.
INTRODUCTION
Parturition has been characterized as the withdrawal of factor(s) implicit in the maintenance of pregnancy [1] [2] [3] . The withdrawal of progesterone (P 4 ) that accompanies parturition in almost all animal species is an example of retreat from pregnancy maintenance. Although parturition in women is not associated with decreasing levels of P 4 in blood, parturition in women and all animal species likely involves withdrawal from endocrinologic factors that inhibit uterine contractions and maintain cervical competency. The recent development of a colony of mice bearing a null allele in the 5␣-reductase type 1 gene (Srd5a1) provides further insight regarding possible mechanisms that may mediate P 4 withdrawal at the tissue level [4] . Mice deficient in 5␣-reductase type 1 (5␣R1) fail to deliver their young at the expected time of parturition; pregnancy often continues until all pups die and undergo resorption or the mother succumbs to complications of sepsis. The mechanism of delayed parturition in these Srd5a1-deficient mice is not the absence of P 4 withdrawal in blood or the absence of uterine contractions at the expected time of parturition but, rather, failure to metabolize P 4 in uterine and cervical tissues at term [4] . These studies in 5␣R1-deficient animals indicate that, in mice, successful parturition is dependent not only on P 4 withdrawal in blood (by way of luteolysis) but also by local tissue metabolism of P 4 by steroid 5␣R1. In addition, it has been suggested that steroid 5␣R1 may be required to generate a 5␣-reduced steroid necessary for initiation of labor [5] .
Steroid 5␣-reductases utilize NADPH to catalyze the conversion of testosterone to dihydrotestosterone and the conversion of other steroids with a 3-oxo-⌬ 4,5 configuration (e.g., P 4 , hydrocortisone, aldosterone, deoxycorticosterone) to 5␣-reduced metabolites. The conversion of testosterone to 5␣-dihydrotestosterone results in generation of a more potent androgen with increased affinity for the androgen receptor. On the other hand, 5␣-reduction of other steroid hormones leads to generation of metabolites with low affinity for their respective nuclear steroid hormone receptors [6] . Thus, 5␣-reductases may exhibit anabolic or catabolic roles depending on their tissue distribution and the steroid hormone receptor expression in those tissues.
In mice, the expression of 5␣R1 mRNA is low in uteri of nonpregnant animals, but expression increases dramatically in the days before parturition, peaking on Days 17-18 [5] . The enzyme is expressed in glandular epithelial cells of gestational endometrium and cervix [4] . These cells also express high levels of P 4 receptors during pregnancy [7] , and the time course of 5␣R1 mRNA expression parallels that of estrogen and P 4 . Although the stimulus for this increase in uterine 5␣R1 is unknown, we considered the possibility that sex-steroid hormones of pregnancy (e.g., estrogen, P 4 ) or uterine occupancy (placenta or fetal factors or stretch [8] ) may regulate the expression of 5␣R1 in target tissues of P 4 action in the female reproductive tract. To investigate these possibilities, we treated ovariectomized mice with estrogen, P 4 , or both, and we utilized a unilateral pregnancy model in which gravid and nongravid uterine horns were exposed to the normal systemic hormonal milieu of pregnancy. We found that estrogen plus P 4 induce 5␣R1 gene expression in uterine tissues. However, the prepartum up-regulation of 5␣R1 was greatly attenuated in the nongravid horn of unilateral pregnant animals. Thus, 5␣R1 is regulated by both fetal occupancy and steroid hormones, like other genes involved in parturition. 
MATERIALS AND METHODS

Hormonal Treatment of Ovariectomized Mice
Adult female ICR mice (3-4 mo of age; Harlan, Indianapolis, IN) were housed under a 12L:12D cycle (lights-on, 0600-1800 h) at 22ЊC with free access to water and standard mice laboratory chow. Ovariectomy was conducted under anesthesia using aseptic conditions with a single ventral incision. After 2 wk, ovariectomized animals were divided into four groups (nine animals per group). Control animals (group 1) received vehicle alone. Group 2 received 17␤-estradiol (E 2 ; 50 g/kg per day), and group 3 received P 4 (1 mg/day). Group 4 received combination treatment (E 2 ϩP 4 ). Steroids were solubilized in corn oil, and injections were administered s.c. in 50-l volumes daily for 3 days. Animals were killed on Day 4. Uterine horns were carefully separated under microscopy and trimmed of excess connective tissue and fat. The cervix and uterine horns were frozen separately in liquid N 2 and stored at Ϫ80Њ.
Unilateral Ligation Studies
Unilateral tubal interruption was conducted under anesthesia (avertin, 25 l/g) by ligation of either the right or left fallopian tube with 8-0 silk suture. Two weeks after ligation, timed matings were carried out by housing one male with three to four females per cage. Each day, females were evaluated for vaginal plugs. Gestational Day 0 was defined by the presence of a plug. Placental discs, fetal pups, and cervix were dissected from uterine tissue at various times in gestation (Days 12-18, n ϭ 26) utilizing dissection microscopy. Uterine tissues were snap-frozen in liquid N 2 and stored at Ϫ80ЊC until used. All studies were conducted in accordance with the standards of humane animal care described in the NIH Guide for the Care and Use of Laboratory Animals using protocols approved by an Institutional Animal Care and Research Advisory Committee.
Enzyme Activity
Tissues were homogenized in buffer that contained 10 mM potassium phosphate, 150 mM KCl, 0.3 M sucrose, and 1 mM EDTA (pH 7.0) with three short pulses of a Brinkman polytron. The concentration of protein in tissue homogenates was determined by the method of Bradford using bovine albumin as a standard. 5␣-Reductase enzyme activity was determined by incubating tissue homogenates (150 g of protein) in 0.1 M Tris-citrate buffer (pH 7.0) containing 1.4 M [ 14 C]testosterone (NEN Research Products, Boston, MA) and 5 mM NADPH (Sigma, St. Louis, MO) for 60 min in a 37ЊC water bath. The reaction was quenched with 5 ml of dichloromethane. Extraction tubes were then vortexed and centrifuged at 2500 rpm for 10 min. Steroids were taken to dryness under a stream of nitrogen and dissolved in 50 l of chloroform/methanol (2:1, v/v), spotted onto Silica Gel 150 thin-layer chromatography plates (product no. 4855-821; Whatman, Clifton, NJ), and resolved by development in chloroform: ethylacetate (3:1, v/v). Radiolabeled steroids (testosterone, R f 0.38; dihydrotestosterone, R f 0.52; and 5␣-androstane-3␣-ol-diol, R f 0.34) were visualized by exposing the plates to Kodak XAR-5 film (Eastman Kodak, Rochester, NY) for 12-16 h and quantified using a PhosphorImager. Nonradioactive standards (Steraloids, Wilton, NH) were cochromatographed on the silica plates and visualized by iodine staining. Specific activity was quantified as the amount of 5␣-reduced products formed per minute per milligram of protein.
Northern Blot Analysis
Total RNA was extracted from tissues using Ultraspec (Biotecx, Houston, TX) according to the manufacturer's directions. Poly(A) ϩ RNA was isolated from total RNA using an mRNA purification kit (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). Poly(A) ϩ RNA (10 g) was sizefractionated by electrophoresis through a 1.4% (w/v) agarose gel, transferred to nylon filters (Biotrans; ICN Corp., Cleveland, OH) by capillary blotting, and hybridized to a 32 P-radiolabeled probe for 5␣R1. The radiolabeled probe was generated by asymmetric polymerase chain reaction using [␣ 32 P]deoxycytosine triphosphate (3000 Ci/mmol) and murine 5␣R1 cDNA as template (10 ng; kindly provided by Dr. David Russell, University of Texas Southwestern Medical Center, Dallas, TX) and oligonucleotide primers corresponding to base pairs (bp) 114-136 (80 nM, 5Ј-GCTCTTCCTACGGCCGCTACTCC-3Ј, forward primer) and bp 373-350 (800 nM, 5Ј-GAAGGCCAAGACAAAGGTGAACAG-3Ј, reverse primer). Prehybridization was conducted at 65ЊC for 2 h. Thereafter, the membrane was hybridized at 65ЊC overnight in 5ϫ SSPE (single strength: 150 mM NaCL, 10 mM NaH 2 PO 4 , and 1 mM Na/EDTA), 50% (v/v) formamide, 5ϫ Denhardt solution, 1% (w/v) SDS, and 7% (w/v) dextran sulfate. The membrane was washed in 2ϫ SSC (single strength: 0.15 M sodium chloride and 0.015 M sodium citrate) and 0.1% SDS for 20 min at 25ЊC, then four washes of 15 min each in 1ϫ SSC and 0.1% SDS at 65ЊC, followed by autoradiographic exposure to x-ray film. Thereafter, the membrane was stripped and reprobed with a 32 P-radiolabeled probe for cyclophilin (with lower specific activity).
Statistical Analysis
Results are expressed as the mean Ϯ SEM. Statistical comparisons between multiple groups were conducted using either an ANOVA followed by Student-Neuman-Keuls post-hoc testing for normally distributed data or a Kruskal-Wallis ANOVA on Ranks followed by post-hoc Dunnett testing for unequally distributed data. Paired comparisons of 5␣R1 activity within animals were made by a two-way ANOVA. A P value of less than 0.05 was considered to be significant.
RESULTS
Effect of Estrogen and P 4 on Expression of 5␣R1 in Uterine Tissues
The 5␣R1 enzymatic activity was low in uterine tissues from control ovariectomized mice, and this level was not increased by treatment with either E 2 or P 4 alone (Fig. 1) . Enzyme activity was significantly increased in uterine tissues from animals treated with E 2 ϩP 4 . In cervical tissues, enzyme activity was more variable than in corresponding uterine horns (Fig. 1B) . However, as with uterine tissue levels, E 2 ϩP 4 increased 5␣R1 activity in the cervix (P Ͻ 0.05) (Fig. 1B) . The variability in expression of enzyme activity in the cervix was probably due to difficulty in precise recognition of the junction between uterine horns and cervix. Therefore, further experiments were conducted with uterine tissues.
The effect of E 2 and P 4 on 5␣R1 mRNA expression was determined by Northern blot analysis using pooled uterine horns from each treatment group (Fig. 2) . The cDNA probe for 5␣R1 detected a strong signal at 2.6 kilobases (kb) and a less intense signal at approximately 1.5 kb in uterine tissues; mRNA for 5␣R1 was not detected in cardiac tissues (negative control). Low levels of 5␣R1 mRNA were detected in uterine tissues from ovariectomized control animals and nonpregnant cycling mice. Treatment with E 2 or P 4 alone resulted in modest increases in the tissue levels of 5␣R1 mRNA, but these increased levels of mRNA were not accompanied by increased enzyme activity (as determined by thin-layer chromatography) (Fig. 1A) . Treatment with E 2 ϩP 4 , however, produced 12-fold increases in 5␣R1 mRNA.
Effect of Fetal Occupancy on Expression of 5␣R1 in Uterine Tissues
Although E 2 ϩP 4 significantly increased the levels of enzyme activity in ovariectomized mice, the level of expression was considerably less than that in uterine tissues from pregnant animals at term (Figs. 3 and 4) . A unilateral pregnant mouse model was utilized to explore the possibility that factors related to fetal occupancy may influence the expression of 5␣R1 during gestation. The 5␣R1 enzyme activity was determined in unilateral pregnant mice as a function of gestational age (Fig. 3) . No significant increase was found in 5␣R1 activity in the nongravid horn from Day 12 to Day 18, and these levels were similar to those of uterine tissues from nonpregnant mice treated with E 2 ϩP 4 (Fig. 4) . In contrast, uterine 5␣R1 activity increased eightfold from Day 12 to Day 18 in the gravid horn (Fig. 3) . In cervical tissues, 5␣R1 activity also increased, from 4.3 Ϯ 1.8 on Days 12-13 (n ϭ 6) to 15.3 Ϯ 2.2 on Day 18 (n ϭ 6, P Յ 0.003). This temporal pattern of 5␣R1 paralleled marked increases in uterine diameter (from 2 mm to 9 mm) (Fig. 3, right) .
Placental Effects of 5␣R1 Activity
In unilateral pregnant animals, fetal occupancy was necessary for gestational-dependent increases in uterine 5␣R1 activity. We considered the possibility that placental-derived substances may influence enzyme activity during gestation. Uterine tissue overlying the placenta was microdis-FIG. 5. Steroid 5␣R1 activity in placental and nonplacental uterine tissues from pregnant animals during late gestation. Enzyme activity was determined in uterine tissues from three nonpregnant cycling animals (Nonpregnant) and in uterine tissues adjacent to the placenta (Pregnant, Placental) or separate from the placenta (Pregnant, Nonplacental) in pregnant animals (Days 17-18). Each bar represents the mean Ϯ SEM of 14 tissues (pool of tissues surrounding two or three fetoplacental units) from three pregnant animals. *P Ͻ 0.001 compared with placental region or nonpregnant uterine tissues.
sected from the nonplacental (distended) uterine tissue, and 5␣-reductase activity was quantified (Fig. 5) . Enzyme activity was significantly increased in the distended nonplacental region of the uterus compared with the uterine tissues adjacent to the placenta. These results indicate that increased 5␣R1 activity in the gravid horn of unilateral pregnant animals is not due to the influence of the placenta.
DISCUSSION
In rodents, 5␣R1 is widely distributed among a variety of tissues, including brain, liver, adrenal, kidney, nongenital skin, ovary, cervix, and uterus [9] . 5␣-Reductase type 2 is expressed in kidney, male adrenal, and androgen-dependent structures (e.g., prostate, epididymis, seminal vesicles) [9] . Expression of 5␣-reductase type 2 in androgen-dependent tissues is essential for sexual differentiation of the external male genitalia [10] . Induction of 5␣-reductase type 2 by testosterone results in the conversion of testosterone to dihydrotestosterone. Dihydrotestosterone not only binds to the androgen receptor but also increases gene expression of 5␣-reductase type 2 by an autoregulatory mechanism, whereby increased testicular androgen production at puberty induces gene expression of 5␣R1 and 5␣-reductase type 2 in target tissues of androgen action [11] . Gene expression is further induced by dihydrotestosterone administration, thereby supporting an additional level of autoregulation. The regulation of steroid 5␣R1, however, is not well characterized.
The wide distribution of 5␣R1 within the female reproductive organs in mice signals its significance in female reproductive function. The principal substrate for 5␣R1 in female reproductive tissues, however, may be P 4 rather than testosterone. Androgen levels are significantly lower in females compared with males, and P 4 levels fluctuate with a cyclic variation. Furthermore, 5␣-reductase is also known to have a higher affinity for P 4 than testosterone. Thus, in female mice, 5␣R1 not only metabolizes androgens but also P 4 to elicit physiologic responses for normal reproductive function in nonpregnant and pregnant states.
The findings presented herein provide evidence that E 2 and P 4 regulate expression of 5␣R1 in the female reproductive tract. Although in some respects regulation of the type 1 enzyme by P 4 is similar to regulation of the type 2 enzyme by testosterone, significant differences exist, because 5␣-dihydroprogesterone is not biologically active with respect to binding to the P 4 receptor. Thus, at first glance, it seems paradoxical that P 4 may induce its own catabolism in P 4 -responsive tissues. However, metabolism of P 4 by the sequential action of 5␣-reductase and 3␣-hydroxysteroid dehydrogenase leads to the formation of 5␣,3␣-hydroxy-dihydroprogesterone (allopregnanolone), which is a biologically active neurosteroid [12] [13] [14] . 5␣-Reduced pregnanolones act predominantly through nongenomic mechanisms to alter cellular function. For example, allopregnanolone directly activates and potentiates GABA-A receptor-activated membrane currents in the brain [15, 16] . Allopregnanolone has also been shown to inhibit action potentials in the brain and to synergize with other neurotransmitters to inhibit action potentials [17] . The GABA receptor subunits are highly expressed in the female reproductive tract [18] [19] [20] . These results, together with the demonstration of marked increases in uterine 3␣-hydroxysteroid dehydrogenase during late gestation [5] , indicate that P 4 induction of 5␣R1 may result not only in P 4 catabolism but also in generation of bioactive 5␣-reduced pregnanolones or androgens. These steroids may affect the activity of uterine or cervical GABA receptors or other cell membrane proteins [21] to facilitate uterine contractions and cervical ripening. Further studies are necessary to test this hypothesis. Nevertheless, the increased expression of 5␣R1 in uterine tissues on Day 14 is insufficient to initiate parturition in the presence of continued P 4 production by the corpus luteum. In the absence of 5␣R1, however, P 4 withdrawal in blood alone is insufficient to induce parturition in mice [4] . Thus, it appears that both are necessary for successful labor and delivery.
In the present studies, both P 4 and fetal occupancy were necessary to obtain maximal levels of 5␣R1 in uterine tissues. Treatment of castrated females with E 2 ϩP 4 resulted in 8-to 10-fold increases in enzyme activity and a similar response in mRNA levels. Numerous studies have documented that, physiologically, estrogen is required to induce P 4 receptor gene expression in P 4 -responsive tissues. Thus, sensitivity to P 4 is indirectly under the control of estrogen.
The observations that estrogen plus P 4 only partially induces uterine 5␣R1 expression in nonpregnant rats and that 5␣R1 is significantly decreased in the nongravid horn relative to the gravid horn of unilateral pregnant mice suggest that the systemic hormonal changes of late pregnancy are insufficient for maximal induction of 5␣R1 expression. Although it is possible that fetal or placental factors affect 5␣R1 expression in a paracrine manner, 5␣-reductase activity in uterine tissues adjacent to the placenta was lower than that in nonplacental uterine tissues. The massive distention of the uterus caused by the rapidly growing fetus provides one explanation for the marked increase in 5␣R1 activity during pregnancy.
Previous studies have established the importance of stretch in increasing transcription of certain genes believed to be important in the initiation of parturition [22] [23] [24] [25] . During normal gestation, growth of the conceptus results in uterine distention. Uterine smooth muscle cells undergo cellular hypertrophy to accommodate the increase in uterine diameter. Endometrial epithelial cells, however, proliferate to line the increased lumenal surface area caused by fetal occupancy. Indeed, it was established as early as 1969 [8] that this endometrial hyperplastic response is mediated by uterine distention rather than by fetal-derived products. In unilateral pregnant mice on Day 18, the lumenal surface area is significantly increased in the gravid horn compared with the empty horn. Thus, increased gene expression of steroid 5␣R1 in the uterus during pregnancy likely is mediated not only by estrogen and P 4 but also by stretchinduced increases in the size and number of endometrial epithelial cells, which are known to express 5␣R1 mRNA [4] . Although E 2 treatment alone induced uterine enlargement and endometrial glandular proliferation, 5␣R1 enzyme activity was not increased. Thus, growth of endometrial epithelial cells in the absence of P 4 was not sufficient to induce 5␣R1 gene expression.
During pregnancy, many proteins are regulated in opposing directions by estrogen and P 4 in reproductive tissues. For example, oxytocin receptors [26] , connexin 43 [27] , cGMP-dependent protein kinase [28] , and interstitial collagenase [29] are up-regulated by E 2 and down-regulated by P 4 . In most species at term, P 4 withdrawal, together with increasing levels of estrogen, leads to increased expression of these genes, thereby providing effective contractions of labor and cervical ripening. The induction of 5␣R1 at term by the combined actions of estrogen plus P 4 plus uterine distention would, eventually, create an environment favorable for labor by removing the opposing actions of P 4 on estrogen-dependent genes (i.e., connexin 43, oxytocin receptors, estrogen receptors, and cervical metalloproteases).
In summary, the mechanisms that lead to the coordinated expression of genes that relieve inhibition of myometrial contractility and promote cervical ripening during parturition have yet to be determined. The elucidation of the involvement of steroid 5␣R1 in parturition has increased our understanding of this process. The data reported herein indicate that 5␣R1 is under tight regulation by coordinated interactions between mechanical and hormonal factors. Regulation of 5␣R1 gene expression in the murine uterus is analogous to that of 5␣-reductase type 2 in the prostate. Both genes are regulated by their substrate hormones (P 4 or testosterone). During gestation, 5␣R1 in uterine tissues is also regulated by fetal occupancy. The induction of 5␣R1 by both hormonal and mechanical signals at term provides an important tissue-specific branch point for the coordinated expression of several parturition-related genes.
